Your fact-checks will appear here
American multinational biopharmaceutical company
Pharmaceutical industry political giving has long skewed Republican but moved toward parity and even Democratic gains in recent years, with evidence of a sustained Republican tilt through much of the ...
OpenSecrets reports Pharmaceuticals/Health Products PACs gave $16,054,355 to federal candidates in 2024 (industry total), and company PACs such as Pfizer and Merck were major players in 2023–24 giving...
OpenSecrets reports the Pharmaceuticals/Health Products sector gave $16,054,355 to federal candidates in 2024; House members who received the largest industry totals included Rep. Brett Guthrie, who O...
’s reported wins for “” cluster around a handful of strategic, industrial sectors: and advanced manufacturing; and mining; and nuclear infrastructure; and and AI-related manufacturing — all supported ...
Open-source tracking groups show that pharmaceutical-sector donations in the 2019–2020 cycle flowed more to Democrats overall than to President Trump, and that individual pharma companies and their em...
Pharmaceutical industry donations and lobbying were a major, organized force in the 2024 healthcare debates, combining tens of millions in direct PAC contributions with hundreds of millions spent on l...
Nine major drugmakers — Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech (Roche’s U.S. unit), Gilead Sciences, GSK (including ViiV), Merck, Novartis and Sanofi — agreed to sell selected me...
Yes — nine major pharmaceutical companies publicly agreed to lower the price of some of their medicines in deals announced by the Trump administration on Dec. 19, 2025, committing to “most-favored-nat...
Vaccine trial sponsors typically release high-level documents — trial registrations, protocols or protocol synopses, journal articles and summary results — while retaining detailed regulatory dossiers...
There is no evidence in the supplied reporting that a molecule named "gelatide" has been evaluated in randomized clinical trials for weight‑loss efficacy or safety; the documents instead describe rand...
Top House recipients of pharmaceutical PAC money in 2020 were part of a broader package of industry giving that totaled millions—STAT reported pharma PACs donated $8.62 million to individual candidate...
Available reporting and trial listings show many anti‑obesity drugs advancing through phase 2 and phase 3, but none of the supplied sources mention an agent named “gelatide” or any randomized phase 2/...
Several credible alternatives to Newself for medication-assisted weight loss exist across two broad categories: prescription GLP‑1 and related drugs (established agents and next‑generation compounds) ...